Drug details

Entadfi (finasteride and tadalafil capsules)

type of

Entadfi (finasteride and tadalafil) is a combination of a 5 alpha-reductase inhibitor and a phosphodiesterase 5 (PDE5) inhibitor indicated to initiate treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate for up to 26 weeks.

This drug may have the following side effects:

• rash,
• back pain,
• headache,
• impotence,
• indigestion,
• muscle pain,
• stuffy nose,
• decreased sex drive,
• breast tenderness,
• decreased volume of ejaculate,
• breast enlargement,
• flushing, and
• limb pain.

The following drugs are related to Entadfi, either as a replacement or used together:

• Uroxatral (alfuzosin hcl)
• Cardura (doxazosin mesylate)
• Cardura XL (doxazosin mesylate extended release tablets)
• Flomax (tamsulosin hydrochloride)
• Hytrin (terazosin hcl)
• Minipress (prazosin hcl)